奥曲肽选择性动脉介入治疗重症急性胰腺炎临床观察

    Octreotide in selective artery interventional therapy for severe acute pancreatitis

    • 摘要: 目的:观察奥曲肽选择性动脉介入治疗重症急性胰腺炎(SAP)的疗效。方法:将63例SAP患者分为对照组和治疗组,对照组36例采用常规治疗,治疗组27例除常规治疗外,采用数字减影血管造影(DSA),根据CT检查所示胰腺病变部位将导管插入胰腺供血动脉,每6 h经导管注入奥曲肽0.1 mg,疗程3~7天。比较两组疗效。结果:治疗组血液淀粉酶较对照组下降迅速,胃肠减压量治疗组与对照组差异有统计学意义(P<0.01),临床治愈时间治疗组比对照组明显缩短(P<0.01),并发症发生率、中转手术率和病死率,治疗组分别为14.81%、3.70%和0.00%,对照组分别为44.44%、22.22%和16.67%。结论:奥曲肽介入治疗SAP疗效显著,且优于常规治疗。

       

      Abstract: Objective: To observe the effect of selective artery interventional therapy with octreotide on severe acute pancreatitis(SAP).Methods: Sixty-three SAP patients were divided into control group(36 cases) and treatment group(27 cases).The control group received only the routine therapy,while the the treatment group received interventional therapy in addition to the routine therapy.A catheter was placed to the pancreas feeding artery according to CT check and digital subtraction angiography(DSA) device,and octreotide 0.1 mg was supplied every 6 h for 3 to 7 days.The curative effects of the two groups were compared.Results: The blood amylase reduced more quickly in the treatment group than in control group.The gastrointestinal decompression was significantly different between the two groups(P<0.01) and the treatment time was shortened obviously in the treatment group(P<0.01).The complication incidence rate,change surgery rate and fatality rate were 14.81%,3.70% and 0.00%,in the treatment group,and 44.44%,22.22% and 16.67% in the control group,respectively.Conclusions: The curative effect of interventional therapy using octreotide is much better than the routine therapy for SAP.

       

    /

    返回文章
    返回